Every ProjMed story ships with clinician, investor, and patient lenses; ELI5 and regulatory depth; and an evidence grade.

The clearance covers three new ultrasound systems, potentially expanding GE HealthCare's premium offerings in diagnostic imaging, though specific clinical enhancements remain undisclosed.

The FDA has granted 510(k) clearance to Roche Diagnostics for its Elecsys EBV VCA IgG assay, an in vitro diagnostic test for Epstein-Barr Virus antibodies. This expands the company's infectious disease diagnostics portfolio.

The clearance of this Class II device suggests a focus on mitigating needlestick injuries for healthcare professionals, leveraging a traditional 510(k) pathway for market entry.

The orthopedic device, intended for spinal stabilization, received a Traditional 510(k) clearance, confirming its substantial equivalence to predicate devices.

The clearance, granted to Fit-Pro KFT (Ltd.) operating as E-Fit, indicates substantial equivalence for its Ultima System and associated accessory packages, suggesting a market entry for non-invasive aesthetic treatments.

The Cardiovascular Advisory Committee review positions Inari Medical's latest device as substantially equivalent, potentially expanding treatment options in a competitive market.

Biolinq Incorporated's novel microsensor, designed for autonomous time-in-range monitoring, has received FDA clearance, signaling a potential expansion in continuous glucose monitoring technologies.

The decision, classifying the device under General and Plastic Surgery, marks a regulatory step for the Korean manufacturer's absorbable sutures in the U.S. market.

The latest version of Epic's predictive algorithm for patient decline has been deemed substantially equivalent, allowing its broader clinical use as a Class II device.

The clearance, received through the traditional 510(k) pathway, designates the device as substantially equivalent for specific dental applications.

The orthopedic device, intended for bunion correction, secured a 'Special' clearance, indicating substantial equivalence to a predicate device.

The clearance, granted via a Traditional 510(k) pathway, designates the device as substantially equivalent for its intended use, expanding Martech Medical's product offerings.

The diagnostic software, classified as a Class II device, is cleared for aiding in cardiovascular risk assessment, expanding the company's presence in medical imaging analysis.

The clearance, granted via a traditional 510(k) pathway, designates the devices as substantially equivalent for their intended use.

The agency deemed the devices substantially equivalent, allowing Shenzhen Mericonn Technology to market four mesh nebulizer models in the U.S.

The device, a Class II accessory intended for endoscopic procedures, received a Substantially Equivalent determination, allowing market access without the need for new clinical trials.

The FDA determined the pulsed light system to be substantially equivalent, clearing its path to the market as a Class II device.

Fotona D.O.O. secured 510(k) clearance for its Dynamis Pro Family of lasers, positioning it for market entry as a substantially equivalent device in plastic surgery.

The FDA’s 'Substantially Equivalent' decision positions the FDB08, FDB08A, and FDB12 models as Class II medical devices for mobility assistance, pending market introduction details.

The company's ureteral access sheath is cleared via the 510(k) pathway, indicating substantial equivalence to a predicate device for urinary tract access.

The CraniUS Plate, a Class II device from CraniUS, LLC, has received FDA 510(k) clearance via a Special submission, signaling its substantial equivalence for specific cranial applications.

The clearance of Potenza Prime expands the market for radiofrequency microneedling, signaling continued regulatory acceptance of established aesthetic technologies.

The CADDIE device, intended for gastroenterology and urology applications, secured a Special 510(k) clearance, signaling substantial equivalence to a predicate device.

The clearance for Digistat Care expands its market access, with further details on its specific functionalities and clinical utility pending.

The FDA granted clearance for Tianjin Huahong Technology's safety lancet, a Class II device intended for single-use blood sampling.

While evidence links ultra-processed foods (UPFs) to adverse health outcomes, experts differ on whether the processing itself or merely their high fat, sugar, and salt content is the primary driver of risk.

Despite significant progress in antiepileptic drugs and device therapies, a substantial portion of epilepsy patients globally remain untreated or inadequately managed, often due to social stigma and systemic healthcare access issues rather than a lack of medical solutions.

The shift in guidance from the Joint Committee on Vaccination and Immunisation follows a significant Meningitis B outbreak in Kent and growing evidence of increased risk in socially active adolescents.

Recent advances in tinnitus treatment emphasize combination therapies and neuromodulation, yet sustained relief remains an elusive goal for many patients, highlighting the need for more robust clinical evidence.

Regulatory differences and reimbursement strategies in the UK are shaping the availability and adoption of oral and injectable GLP-1 receptor agonists for weight management, with implications for patient access and market dynamics.